ユタにおける肺がんの臨床試験
ユタ内の拠点で、肺がんに関する25件の研究が参加者を募集しています。
ユタ内の都市
公式研究テキスト（英語）
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- Utah Cancer Specialists, Salt Lake City
- Huntsman Cancer Institute, Salt Lake City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06881784SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier
- University of Utah, Salt Lake City
- Veterans Affairs SLC Health Care System (VAMC), Salt Lake City
被験者募集中観察研究健康なボランティア歓迎
21歳以上 · 全性別 · 2026/09/28更新 · NCT07460440A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Huntsman Cancer Institute ( Site 0042), Salt Lake City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06312137Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Huntsman Cancer Institute, University of Utah, Salt Lake City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07222566A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Huntsman Cancer Institute, Salt Lake City
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07063745Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- Utah Cancer Specialists, Salt Lake City
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06712316A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- START Mountain Region, West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06400472AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, West Valley City
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/09/04更新 · NCT07038343Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- Huntsman Cancer Institute, Salt Lake City
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06343402Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- Huntsman Cancer Institute/University of Utah, Salt Lake City
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06500481Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics
- Huntsman Cancer Institute/ University of Utah, Salt Lake City
被験者募集中健康なボランティア歓迎
50歳〜80歳 · 全性別 · 2026/07/21更新 · NCT07716280A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Huntsman Cancer Institute, University of Utah, Salt Lake City
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/29更新 · NCT07458347Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Huntsman Cancer Institute/University of Utah, Salt Lake City
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/03更新 · NCT05642572A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- START Mountain Region, West Valley City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/28更新 · NCT07223047Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Huntsman Cancer Institute, Salt Lake City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/15更新 · NCT05379985Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
- Huntsman Cancer Institute, University of Utah, Salt Lake City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/14更新 · NCT06922591Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Huntsman Cancer Institute/University of Utah, Salt Lake City
被験者募集中第2相
18 Minutes · 全性別 · 2026/05/05更新 · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Huntsman Cancer Institute/University of Utah, Salt Lake City
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/05/05更新 · NCT06616584Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
被験者募集中
18歳以上 · 全性別 · 2026/04/30更新 · NCT05297734A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Huntsman Cancer Institute, Salt Lake City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/22更新 · NCT07020221Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- University of Utah, Huntsman Cancer Institute, Salt Lake City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06810544A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- START Mountain Region, West Valley City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/18更新 · NCT06244771Improving Care for Rural Patients With Solid Tumors
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
被験者募集中
18歳〜99歳 · 全性別 · 2026/02/05更新 · NCT04916990VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Utah Cancer Specialists (site 203), Salt Lake City
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2025/12/11更新 · NCT03556228SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Salt Lake City
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。